Decreased expression of heparin-binding epidermal growth factor–like growth factor as a newly identified pathogenic mechanism of antiphospholipid-mediated defective placentation
Version of Record online: 25 JAN 2010
Copyright © 2010 by the American College of Rheumatology
Arthritis & Rheumatism
Volume 62, Issue 5, pages 1504–1512, May 2010
How to Cite
Di Simone, N., Marana, R., Castellani, R., Di Nicuolo, F., D'Alessio, M. C., Raschi, E., Borghi, M. O., Chen, P. P., Sanguinetti, M., Caruso, A. and Meroni, P. L. (2010), Decreased expression of heparin-binding epidermal growth factor–like growth factor as a newly identified pathogenic mechanism of antiphospholipid-mediated defective placentation. Arthritis & Rheumatism, 62: 1504–1512. doi: 10.1002/art.27361
- Issue online: 29 APR 2010
- Version of Record online: 25 JAN 2010
- Accepted manuscript online: 25 JAN 2010 12:00AM EST
- Manuscript Accepted: 11 JAN 2010
- Manuscript Received: 24 NOV 2008
- 3T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: differential production and release by CD4+ and CD8+ T cells. Proc Natl Acad Sci U S A 1994; 91: 2890–4., , , , .
- 14Pathogenic role of anti-β2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of β2-glycoprotein I binding to trophoblast cells and functional effects of anti-β2-glycoprotein I antibodies in vitro. Ann Rheum Dis 2005; 64: 462–7., , , , , , et al.
- 30Heparin inhibits the binding of β2-glycoprotein I to phospholipids and promotes the plasmin-mediated inactivation of this blood protein: elucidation of the consequences of the two biological events in patients with the anti-phospholipid syndrome. J Biol Chem 2002; 277: 2644–9., , , , , .